Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Anecortave; Hydrocortisone

Criteria

Inclusion Criteria:

• Either gender

• 18 years of age or older

• IOP elevation caused by steroid usage

• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Under 18 years of age

• Other protocol-defined exclusion criteria may apply